Atlas Trials

An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer

Clinical trial NCT01964144 · COMPLETED

Trial details

NCT number
NCT01964144
Sponsor
Yonsei University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Thyroid Cancer
Start date
2013-01-01
Primary completion
2014-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.